Alzheimer's drugs

Galimedix's oral Alzheimer's candidate clears ph. 1 safety test

The small molecule caused no serious adverse events and successfully crossed the blood-brain barrier in a trial with more than 100 healthy volunteers.

Darren Incorvaia Sep 12, 2025 11:11am

Prothena Alzheimer's trial hit by ARIA showstopper

Aug 28, 2025 6:48am

Denali Alzheimer's antibody clears plaques without ARIA in mice

Aug 7, 2025 2:00pm

boxing punch blow hit punching bag fight

Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout

Apr 10, 2025 8:48am

Alzheimers research brain scientist magnifying glass questions neuro

AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug

Oct 28, 2024 10:00am

Vivoryon Alzheimer’s drug fails phase 2 trial, crashing stock

Mar 4, 2024 8:13am